Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Current Taxes (2023 - 2024)

Sutro Biopharma's Current Taxes history spans 2 years, with the latest figure at $18000.0 for Q4 2024.

  • For Q4 2024, Current Taxes fell 99.88% year-over-year to $18000.0; the TTM value through Dec 2024 reached $18000.0, down 99.88%, while the annual FY2024 figure was $18000.0, 99.88% down from the prior year.
  • Current Taxes for Q4 2024 was $18000.0 at Sutro Biopharma, roughly flat from $18000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $15.2 million in Q4 2023 and bottomed at $11000.0 in Q2 2024.